Search Results - "Saubadu, Stephane"

Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M) by AHREN, B. O, DIMAS, Aniceto Leguizamo, MIOSSEC, Patrick, SAUBADU, Stéphane, ARONSON, Ronnie

“…To examine the efficacy and safety of lixisenatide (20 μg once daily, administered before the morning or evening meal) as add-on therapy in patients with type…”
Get full text

Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial by Kuhle, Jens, Chitnis, Tanuja, Banwell, Brenda, Tardieu, Marc, Arnold, Douglas L, Rawlings, Andreea M, Geertsen, Svend S, Lublin, Alex L, Saubadu, Stephane, Truffinet, Philippe, Kappos, Ludwig

“…Background: The phase 3 TERIKIDS study demonstrated efficacy and manageable safety for teriflunomide versus placebo in children with relapsing multiple…”
Get full text

Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS by Chitnis, Tanuja, Banwell, Brenda, Kappos, Ludwig, Arnold, Douglas L, Gücüyener, Kivilcim, Deiva, Kumaran, Saubadu, Stephane, Hu, Wenruo, Benamor, Myriam, Le-Halpere, Annaig, Truffinet, Philippe, Tardieu, Marc

“…Background: The double-blind TERIKIDS study demonstrated the efficacy and safety of teriflunomide. Objective: To evaluate the efficacy, safety, and…”
Get full text

Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Phase 2 Trial (P10-6.001) by Vermersch, Patrick, Saubadu, Stephane, Truffinet, Philippe, Arnould, Benoit, Hakimi-Hawken, Natalia, Minor, Charles, Araujo, Lita, Gourlain, Samuel, Msihid, Jerome, Giovannoni, Gavin

“…Abstract only…”
Get full text

Safety and Efficacy of Frexalimab in Relapsing Multiple Sclerosis: 48-week Results from the Phase 2 Open-label Extension (S31.007) by Giovannoni, Gavin, Granziera, Cristina, Mao-Draayer, Yang, Cutter, Gary, Kalbus, Oleksandr, Staikov, Ivan, Dufek, Michal, Saubadu, Stephane, Bejuit, Raphael, Djukic, Biljana, Truffinet, Philippe, Wallstroem, Erik, Vermersch, Patrick

“…Abstract only…”
Get full text

Inhibition of CD40L with Frexalimab in Multiple Sclerosis by Vermersch, Patrick, Granziera, Cristina, Mao-Draayer, Yang, Cutter, Gary, Kalbus, Oleksandr, Staikov, Ivan, Dufek, Michal, Saubadu, Stephane, Bejuit, Raphael, Truffinet, Philippe, Djukic, Biljana, Wallstroem, Erik, Giovannoni, Gavin

“…In a phase 2 trial involving participants with multiple sclerosis, the CD40L inhibitor frexalimab reduced the accumulation of new lesions on MRI at week 12 of…”
Get full text

Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial by Chitnis, Tanuja, Banwell, Brenda, Kappos, Ludwig, Arnold, Douglas L, Gücüyener, Kivilcim, Deiva, Kumaran, Skripchenko, Natalia, Cui, Li-Ying, Saubadu, Stephane, Hu, Wenruo, Benamor, Myriam, Le-Halpere, Annaig, Truffinet, Philippe, Tardieu, Marc, Dubois, Benedicte, Verhelst, Helene, Bojinova-Tchamova, Veneta, Mah, Jean, Cui, Li-Ying, Fang, Fang, Hao, Yunpeng, Jiang, Li, Li, Ling, Mao, Ding'An, Qiu, Wei, Tan, Guojun, Wu, Ye, Zhang, Meini, Zhou, Hongyu, Zhou, Shuizhen, Gross-Paju, Katrin, Cheuret, Emmanuel, Deiva, Kumaran, Edan, Giles, Vukusic, Sandra, Chrousos, George, Zafeiriou, Dimitrios, Achiron, Anat, Vaknin-Dembinsky, Adi, Yamout, Bassem, Laurynaitiene, Jurate, Vaiciene-Magistris, Nerija, Bojkovski, Vladimir, Trajkova, Vesna, Chaouki, Sana, Kissani, Najib, Neuteboom, Rinze, Palavra, Filipe, Belova, Anna, Boyko, Alexey, Evdoshenko, Evgeny, Kairbekova, Ekaterina, Malkova, Nadezhda, Shumilina, Maria, Skripchenko, Natalya, Nikolic, Dimitrije, Meca-Lallana, Jose, Triki, Chahnez Charfi, Chokri, Mhiri, Gouider, Riadh, Anlar, Banu, Gücüyener, Kivilcim, Hiz, Ayse Semra, Idiman, Egemen, Turkoglu, Recai, Yapici, Zuhal, Yilmaz, Unsal, Tantsura, Lyudmyla, Voloshyna, Nataliia, Lim, Ming, Wassmer, Evangeline, Cascione, Mark, Chitnis, Tanuja, LaGanke, Christopher, Rathke, Kevin, Scagnelli, John

“…Therapeutic options for children with multiple sclerosis are scarce. Teriflunomide is approved in more than 80 countries for the treatment of adults with…”
Get full text

Oral venglustat in Parkinson disease patients with a mutation: Study design of part 2 of the MOVES-PD trial and patient characteristics by Peterschmitt, M. Judith, Gurevich, Tanya, Gasser, Thomas, Saiki, Hidemoto, Isaacson, Stuart, Waters, Cheryl, Wills, Anne-Marie, Hassin-Baer, Sharon, Simuni, Tanya, Gaemers, Sebastiaan J.M., Sardi, S. Pablo, Saubadu, Stephane, Minini, Pascal, Fischer, Tanya

Get full text

Oral venglustat in Parkinson disease patients with a GBA mutation: Study design of part 2 of the MOVES-PD trial and patient characteristics by Peterschmitt, M. Judith, Gurevich, Tanya, Gasser, Thomas, Saiki, Hidemoto, Isaacson, Stuart, Waters, Cheryl, Wills, Anne-Marie, Hassin-Baer, Sharon, Simuni, Tanya, Gaemers, Sebastiaan J.M., Sardi, S. Pablo, Saubadu, Stephane, Minini, Pascal, Fischer, Tanya

Get full text

Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson’s disease patients with a GBA mutation (S4.002) by Fischer, Tanya, Gasser, Thomas, Isaacson, Stuart, Kulisevsky, Jaime, Mir, Pablo, Simuni, Tanya, Wills, Anne Marie, Guedes, Leonor Correia, Svenningsson, Per, Waters, Cheryl, Ji, Allena, Li, Jian, Minini, Pacal, Nembo, Blandine, Sardi, S. Pablo, Saubadu, Stéphane, Sharma, Jyoti, Peterschmitt, M. Judith

“…Abstract only…”
Get full text

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in the Japanese and the Rest of the World Parkinson’s Disease Population With a GBA Mutation: Results from Part 1 of the MOVES-PD Study (809) by Peterschmitt, M. Judith, Saiki, Hidemoto, Hatano, Taku, Gasser, Thomas, Isaacson, Stuart, Kulisevsky, Jaime, Simuni, Tanya, Takahashi, Yuji, Wills, Anne-Marie, Guedes, Leonor Correia, Svenningsson, Per, Takahashi, Ryosuke, Waters, Cheryl, Katsuno, Masahisa, Ji, Allena Ji, Gaemers, Sebastiaan J. M., Minini, Pascal, Nembo, Blandine, Sardi, Pablo, Saubadu, Stéphane, Sharma, Jyoti, Fischer, Tanya

“…Abstract only…”
Get full text

Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation by Judith Peterschmitt, M., Gasser, Thomas, Isaacson, Stuart, Kulisevsky, Jaime, Mir, Pablo, Simuni, Tanya, Wills, Anne-Marie, Guedes, Leonor Correia, Svenningsson, Per, Waters, Cheryl, Ji, Allena J., Li, Jian, Minini, Pascal, Nembo, Blandine, Saubadu, Stéphane, Sharma, Jyoti, Fischer, Tanya

“…Mutations in GBA are associated with increased risk of developing Parkinson disease (PD), characterized by younger onset, higher prevalence of cognitive…”
Get full text

Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 1 of the MOVES-PD study by Peterschmitt, M. Judith, Saiki, Hidemoto, Hatano, Taku, Gasser, Thomas, Isaacson, Stuart, Kulisevsky, Jaime, Simuni, Tanya, Takahashi, Yuji, Wills, Anne-Marie, Guedes, Leonor Correia, Svenningsson, Per, Takahashi, Ryosuke, Waters, Cheryl, Katsuno, Masahisa, Ji, Allena Ji, Gaemers, Sebastiaan J.M., Minini, Pascal, Nembo, Blandine, Sardi, Pablo, Saubadu, Stéphane, Sharma, Jyoti, Fischer, Tanya

Get full text

Betaxolol versus Carvedilol in Chronic Heart Failure (BETACAR Study) by Böhler, Steffen, Saubadu, Stéphane, Scheldewaert, Rudy, Figulla, Hans-Reiner

“…Summary The use of beta-blockers in heart failure for a long time was regarded as contra-indicated because of their negative inotropic effects. Nevertheless,…”
Get full text

Betaxolol versus carvedilol in chronic heart failure (BETACAR Study) : Rationale and design by BÖHLER, S, SAUBADU, S, SCHELDEWAERT, R, FIGULLA, H.-R

“…The use of beta-blockers in heart failure for a long time was regarded as contra-indicated because of their negative inotropic effects. Nevertheless, there is…”
Get full text